Universal Ibogaine Announces Formation Of Advisory Board
Calgary, AB – TheNewswire – November 08, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce the formation of an external Advisory Board as part of its strategic plans and mission to deliver medicalized ibogaine-centered addiction care and to undertake a planned clinical trial application process.
The UI Advisory Board is intended to allow the Company to draw on a broad range of expertise and experience of its members from various fields, including medical practice, First Nations leadership, psychedelics research, government relations and grant funding. The initial members joining the UI Advisory Board include:
Melissa Lavasani – Melissa Lavasani is Founder and Executive Director of Psychedelic Medicine Coalition, a Washington DC based organization advocating for all plant medicines and their synthetic derivatives at the national, state, and local levels. Melissa proposed DC’s Initiative 81, “The Entheogenic Plant and Fungus Policy Act of 2020,” after entheogenic plants and fungi helped her overcome severe postpartum depression. As Chairwoman, she successfully ran the Decriminalize Nature DC, the campaign supporting the historic passage of Initiative 81. After the use of psilocybin and ayahuasca helped her reclaim her life, Melissa was motivated to change laws in the District of Columbia so that other residents would not face the same fear of investigation, arrest, and prosecution for using psychedelics to heal themselves.
Marcos Moura – Marcos Moura is co-owner and Chief Development Officer of Amada Franchise Inc., a brand dedicated to enriching the lives of our rapidly aging population. Marcos has received Recognition for Amada Senior Care including Top 10 Best New Franchises to Invest In” by Entrepreneur Magazine, #245 on Entrepreneur Magazine’s Franchise 500 Ranking and Inc. 5000 fasted growing companies. Marcos has helped hundreds of entrepreneurs grow businesses that allow them to live life on their terms and do work that is meaningful to them, their families, and their communities. Marcos holds an MBA from the University of Southern California (USC) and works and lives in San Clemente, CA, with his wife and three boys.
Grand Chief Jerry Daniels – Grand Chief of the Southern Chiefs’ Organization (“SCO”), which represents 34 Anishnaabe and Dakota communities in southern Manitoba. In January of 2020; Chief Daniels was acclaimed for a second term noting that this is the first time a Grand Chief has run unopposed in SCO’s history. Chief Daniels graduated from the University of Manitoba with a Bachelor of Arts degree in economics, and he is the owner of Innovative Educational Business. Collectively First Nations are one of the key drivers of Manitoba’s economy, and Chief Daniels focus is on improving the quality of life through key initiatives in the First Nations health care experience, including designing and building community care models consistent with the evolution of the children’s welfare system as envisioned by southern First Nations. Grand Chief Daniels serves on boards and councils at the local, regional, and national levels.
Travis Hayes – Travis Hayes is the founder and CEO of Hayco Construction, a design-build general contractor with extensive experience in the development and construction of medical facilities across Canada and the USA. Travis is leader in addiction recovery in his community and has personally experienced the incredible healing powers of ibogaine, and like others who have done so, Travis is dedicated to bringing the medicalized ibogaine treatment model to the world.
About Universal Ibogaine Inc.
UI is a life sciences company, with a mission to transform addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorder, and ultimately to utilize that protocol globally through planned future licensing agreements. UI is concurrently developing a state of the art holistic addiction treatment protocol at its Kelburn Recovery Centre that, which when paired with the planned ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements and information. Forward-looking information is frequently characterized by words such as “plans”, “expect”, “project”, “intend”, “will”, “believe”, “anticipate”, “estimate”, “scheduled”, ”potential”, or other similar words, or statements that certain events or conditions “may”, “should” or ”could” occur. The forward-looking statements and information are based on certain key expectations and assumptions made by UI. Although UI believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because UI can give no assurance that they will prove to be correct.
Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks, which include, but are not limited to, risks that required regulatory approvals are not obtained. The reader is cautioned that assumptions used in the preparation of such information, although considered reasonable by UI at the time of preparation, may prove to be incorrect and readers are cautioned not to place undue reliance on forward-looking information, which speaks only to conditions as of the date hereof. UI does not undertake any obligation to release publicly any revisions to forward-looking information contained herein to reflect events or circumstances that occur after the date hereof or to reflect the occurrence of unanticipated events, except as may be required under applicable securities laws.
For further information:
Investor Relations: Dugan Selkirk, Investor Relations Manager